Gastric bypass surgery elevates NT-ProBNP levels

Obesity Surgery

Volumn 23, Issue 9, 2013, Pages 1421-1426

  Abrahamsson, Niclas ^a   Engström, Britt Edén ^a   Sundbom, Magnus ^a   Karlsson, F Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Gastric bypass surgery; NT ProBNP; Obesity; Obesity paradox

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GLUCOSE; INSULIN; LOSARTAN; SIMVASTATIN; SOTALOL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HUMAN; INSULIN BLOOD LEVEL; MALE; OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GASTROPLASTY; HEART FAILURE; HOMEOSTASIS; HUMANS; INSULIN; MALE; NATRIURETIC PEPTIDE, BRAIN; OBESITY, MORBID; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84881153157     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0889-z     Document Type: Article

References (38)

1. Tzotzas T, Evangelou P, Kiortsis DN. Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev. 2011;12:e282-9.
2. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925-32.
3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-7. (Pubitemid 34764819)
4. Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:91-6. (Pubitemid 23027559)
5. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50(25):2357-8. (Pubitemid 50011582)
6. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-12.
7. Kerr MA, Kenny AJ. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J. 1974;137:477-88.
8. Kullberg J, Sundbom M, Haenni A, et al. Gastric bypass promotes more lipid mobilization than a similar weight loss induced by a low-calorie diet. J Obes. 2011;2011:959601.
9. Sengenes, Lafontan et al. Natriuretic peptides: a new lipolytic pathway in human fat cells. Med Sci (Paris). 2005;21:29-33.
10. Nishikimi T, Kuwahara K, Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol. 2011;57:131-40.
11. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-8. (Pubitemid 28366422)
12. Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol. 2008;101:3-8. (Pubitemid 351173927)
13. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014-21.
14. Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation. 2002;106:2913-8. (Pubitemid 35424741)
15. Ryding AD, Kumar S, Worthington AM, et al. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology. 2009;111:311-9.
16. Khan A, Cheng S, Melander O, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab. 2011;96:3242-9.
17. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594-600. (Pubitemid 38198866)
18. Lorgis L, Cottin Y, Danchin N, et al. Impact of obesity on the prognostic value of the N-terminal pro-B-type natriuretic peptide (NT-proBNP) in patients with acute myocardial infarction. Heart. 2011;97:551-6.
19. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590-5. (Pubitemid 38561338)
20. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation. 2005;112:2163-8. (Pubitemid 41475811)
21. Minami J, Nishikimi T, Matsuoka H. Plasma brain natriuretic peptide and N-terminal proatrial natriuretic peptide levels in obese patients: a cause or result of hypertension? Circulation. 2004;109:594-600. (Pubitemid 38198866)
22. Hanusch-Enserer U, Hermann KM, Cauza E, et al. Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese. Obes Res. 2003;11:695-8. (Pubitemid 41151595)
23. Minami J, Nishikimi T, Ishimitsu T, et al. Effect of a hypocaloric diet on adrenomedullin and natriuretic peptides in obese patients with essential hypertension. J Cardiovasc Pharmacol. 2000;36 Suppl 2:S83-6.
24. McMurray Jr RW, Vesely DL. Calorie-restricted weight reduction, blood pressure, and atrial natriuretic peptides. Nutrition. 1993;9:178-82. (Pubitemid 23131609)
25. Changchien EM, Ahmed S, Betti F, et al. B-type natriuretic peptide increases after gastric bypass surgery and correlates with weight loss. Surg Endosc. 2011;25:2338-43.
26. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9. (Pubitemid 15018832)
27. Finsterer U, Weber W, Lühr HG. Electrolyte balance in major abdominal surgery. On insensible water losses from the peritoneal cavity. Anaesthesist. 1980;29:59-70. (Pubitemid 10152856)
28. Cagini L, Capozzi R, Tassi V, et al. Fluid and electrolyte balance after major thoracic surgery by bioimpedance and endocrine evaluation. Eur J Cardiothorac Surg. 2011;40:e71-6.
29. Proczko-Markuszewska M, Stefaniak T, Kaska L, et al. Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients. Surg Endosco. 2012;26(8):2202-7.
30. Smith MW, Espiner EA, Yandle TG, et al. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol. 2000;167:239-46.
31. Sarzani R, Dessi-Fulgheri P, Paci VM, et al. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest. 1996;19:581-5. (Pubitemid 26408098)
32. Bartels ED, Nielsen JM, Bisgaard LS, et al. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology. 2010;151:5218-25.
33. Dirksen C, Jorgensen NB, Boysen-Moller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia. 2012;55:1890-901.
34. Hausenloy D, Yellon D. GLP-1 therapy beyond glucose control. Circ Heart Fail. 2008;1:147-9.
35. Nikolaidis LA, Mankad S, Sokos GG, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion. Circulation. 2004;109:962-5. (Pubitemid 38282847)
36. Bose AK, Mocanu MM, Carr RD, et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes. 2005;54:146-51. (Pubitemid 40105106)
37. Key KA, Gall DG, MacNaughton WK. Distribution and function of brain natriuretic peptide in the stomach and small intestine of the rat. Regul Pept. 1991;34:61-70.
38. Sundbom M, Holdstock C, Edén B. Engström, et al. Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obesity Surgery. 2007;17:304-10. (Pubitemid 46659288)